Market Overview:
The global pyrosequencing market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for pyrosequencing in drug discovery, biomarker discovery, personalized medicine, and agriculture and animal research applications. Additionally, the growing demand for sequencing services from research centers and academic/government institutes is also contributing to the growth of the market. However, factors such as high cost of instruments and lack of skilled professionals are restraining the growth of this market.
Product Definition:
Pyrosequencing is a high throughput sequencing technology. It is used to determine the sequence of DNA molecules. The importance of pyrosequencing is that it can be used to detect mutations in the genome.
Diagnostics:
Pyrosequencing is a method that allows the sequencing of nucleic acids, which are extracted from biological samples. It involves the use of pyrosequencing instruments and reagents, as well as software programs. The data generated by these programs is used for analyzing and interpreting genetic structures in terms of functions & mutations etc., to study diseases progression & develop new therapies etc.
The market size was valued at USD 1,849.1 million in 2015.
Drug Discovery:
Drug discovery is the process of developing new drugs or increasing the potency of known drugs by analyzing them for their therapeutic properties. Drug discovery can be performed using various approaches such as in silico screening, combinatorial chemistry, and synthesis optimization. The drug discovery market is expected to witness lucrative growth over the forecast period owing to factors such as growing prevalence of diseases requiring effective therapeutics and rising demand for novel medicines with higher efficacy from patients and physicians.
Application Insights:
Research centers and academic/government institutes held the largest share of over 70.0% in 2017. This is attributed to the rising number of research projects at these centers that use pyrosequencing for various purposes, such as disease diagnosis, drug discovery & development, personalized medicine and agriculture & animal research. Pyrosequencing has also been used in studies related to human health by private companies and non-profit organizations for genetic analysis of individuals or populations.
For instance, a study published in April 2018 by The Wellcome Trust Sanger Institute analyzed the complete genome sequences of two ancient Egyptian mummies - one male dating back around 3500 years BCE and another female who lived around 1500 years BCE - through pyrosequencing technology along with other techniques including traditional DNA sequencing technologies. Such examples illustrate the potential utility of this technology not only across different applications but also across different time periods depending on when this technique was developed last (time period).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of players, continuous research activities for development of new assays, and increasing investments by companies. Moreover, growing personalized medicine industry is expected to drive the regional demand over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising healthcare expenditure and improving infrastructure in countries such as China and India. In addition, government initiatives for disease management are also expected favorably impact revenue generation in this region over next eight years (2018-2030).
Growth Factors:
- Increasing demand for personalized medicine
- Rising prevalence of target diseases
- Technological advancements in pyrosequencing instruments and assay kits
- Growing number of research collaborations and initiatives to develop novel pyrosequencing applications
- Increasing investments in life sciences sector
Scope Of The Report
Report Attributes
Report Details
Report Title
Pyrosequencing Market Research Report
By Type
Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture and Animal Research, Others
By Application
Research Centers & Academic/Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others
By Companies
Beijing Genomics Institute (BGI), Cegat (Centre for Genomics and Transcriptomics), Eurofins Genomics, Febit / Comprehensive Biomarker Center (CBC), Genomnia, Illumina, Macrogen, Microsynth AG, Seqomics, Source Bio Science, Pyrosequencing AB
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
245
Number of Tables & Figures
172
Customization Available
Yes, the report can be customized as per your need.
Global Pyrosequencing Market Report Segments:
The global Pyrosequencing market is segmented on the basis of:
Types
Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture and Animal Research, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Research Centers & Academic/Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Beijing Genomics Institute (BGI)
- Cegat (Centre for Genomics and Transcriptomics)
- Eurofins Genomics
- Febit / Comprehensive Biomarker Center (CBC)
- Genomnia
- Illumina
- Macrogen
- Microsynth AG
- Seqomics
- Source Bio Science
- Pyrosequencing AB
Highlights of The Pyrosequencing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Diagnostics
- Drug Discovery
- Biomarker Discovery
- Personalized Medicine
- Agriculture and Animal Research
- Others
- By Application:
- Research Centers & Academic/Government Institutes
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pyrosequencing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pyrosequencing is a sequencing technology that uses pyrosequencing DNA polymerase to generate millions of short, overlapping reads of the target sequence. These reads can then be assembled into a genome-wide map of the target sequence.
Some of the key players operating in the pyrosequencing market are Beijing Genomics Institute (BGI), Cegat (Centre for Genomics and Transcriptomics), Eurofins Genomics, Febit / Comprehensive Biomarker Center (CBC), Genomnia, Illumina, Macrogen, Microsynth AG, Seqomics, Source Bio Science, Pyrosequencing AB.
The pyrosequencing market is expected to grow at a compound annual growth rate of 10.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Pyrosequencing Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Pyrosequencing Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Pyrosequencing Market - Supply Chain
4.5. Global Pyrosequencing Market Forecast
4.5.1. Pyrosequencing Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Pyrosequencing Market Size (000 Units) and Y-o-Y Growth
4.5.3. Pyrosequencing Market Absolute $ Opportunity
5. Global Pyrosequencing Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Pyrosequencing Market Size and Volume Forecast by Type
5.3.1. Diagnostics
5.3.2. Drug Discovery
5.3.3. Biomarker Discovery
5.3.4. Personalized Medicine
5.3.5. Agriculture and Animal Research
5.3.6. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Pyrosequencing Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Pyrosequencing Market Size and Volume Forecast by Application
6.3.1. Research Centers & Academic/Government Institutes
6.3.2. Hospitals & Clinics
6.3.3. Pharmaceutical & Biotechnology Companies
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Pyrosequencing Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Pyrosequencing Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Pyrosequencing Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Pyrosequencing Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Pyrosequencing Demand Share Forecast, 2019-2026
9. North America Pyrosequencing Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Pyrosequencing Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Pyrosequencing Market Size and Volume Forecast by Application
9.4.1. Research Centers & Academic/Government Institutes
9.4.2. Hospitals & Clinics
9.4.3. Pharmaceutical & Biotechnology Companies
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Pyrosequencing Market Size and Volume Forecast by Type
9.7.1. Diagnostics
9.7.2. Drug Discovery
9.7.3. Biomarker Discovery
9.7.4. Personalized Medicine
9.7.5. Agriculture and Animal Research
9.7.6. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Pyrosequencing Demand Share Forecast, 2019-2026
10. Latin America Pyrosequencing Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Pyrosequencing Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Pyrosequencing Market Size and Volume Forecast by Application
10.4.1. Research Centers & Academic/Government Institutes
10.4.2. Hospitals & Clinics
10.4.3. Pharmaceutical & Biotechnology Companies
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Pyrosequencing Market Size and Volume Forecast by Type
10.7.1. Diagnostics
10.7.2. Drug Discovery
10.7.3. Biomarker Discovery
10.7.4. Personalized Medicine
10.7.5. Agriculture and Animal Research
10.7.6. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Pyrosequencing Demand Share Forecast, 2019-2026
11. Europe Pyrosequencing Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Pyrosequencing Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Pyrosequencing Market Size and Volume Forecast by Application
11.4.1. Research Centers & Academic/Government Institutes
11.4.2. Hospitals & Clinics
11.4.3. Pharmaceutical & Biotechnology Companies
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Pyrosequencing Market Size and Volume Forecast by Type
11.7.1. Diagnostics
11.7.2. Drug Discovery
11.7.3. Biomarker Discovery
11.7.4. Personalized Medicine
11.7.5. Agriculture and Animal Research
11.7.6. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Pyrosequencing Demand Share, 2019-2026
12. Asia Pacific Pyrosequencing Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Pyrosequencing Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Pyrosequencing Market Size and Volume Forecast by Application
12.4.1. Research Centers & Academic/Government Institutes
12.4.2. Hospitals & Clinics
12.4.3. Pharmaceutical & Biotechnology Companies
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Pyrosequencing Market Size and Volume Forecast by Type
12.7.1. Diagnostics
12.7.2. Drug Discovery
12.7.3. Biomarker Discovery
12.7.4. Personalized Medicine
12.7.5. Agriculture and Animal Research
12.7.6. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Pyrosequencing Demand Share, 2019-2026
13. Middle East & Africa Pyrosequencing Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Pyrosequencing Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Pyrosequencing Market Size and Volume Forecast by Application
13.4.1. Research Centers & Academic/Government Institutes
13.4.2. Hospitals & Clinics
13.4.3. Pharmaceutical & Biotechnology Companies
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Pyrosequencing Market Size and Volume Forecast by Type
13.7.1. Diagnostics
13.7.2. Drug Discovery
13.7.3. Biomarker Discovery
13.7.4. Personalized Medicine
13.7.5. Agriculture and Animal Research
13.7.6. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Pyrosequencing Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Pyrosequencing Market: Market Share Analysis
14.2. Pyrosequencing Distributors and Customers
14.3. Pyrosequencing Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Beijing Genomics Institute (BGI)
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Cegat (Centre for Genomics and Transcriptomics)
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Eurofins Genomics
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Febit / Comprehensive Biomarker Center (CBC)
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Genomnia
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Illumina
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Macrogen
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Microsynth AG
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Seqomics
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Source Bio Science
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Pyrosequencing AB
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
